The EMAW platform enables sponsors to achieve better clinical outcomes and enhance study execution

Our single validated technology stack means we collect eCOAs and standardize multimodal data much faster than legacy platforms, structure it for immediate actionable insights and facilitate real-time data transfers and access.

The cloud-based EMAW platform has proven it can uniquely leverage technology, data and AI to generate evidence-based outcomes with unparalleled precision and greater effect size to meet previously unmet needs in CNS.

eCOA infrastructureReal-time clinical detection dataStructured data lakeAPI access on demandLLM quality review in active trialsPhase 2 & 3 global deploymentComposite endpointsReal-time clinical signal detection

Why the architecture matters

The strength of a single-stack unified platform

 

Legacy eCOA platforms were built by the acquisition of disparate technologies and these disconnected systems preclude real-time insights and complicate data transfers.

EMA Wellness platform graphic showing multimodal data, raw transformational and derivative data, Agentic AI capabilities, study enhancements, and two to four week configuration and database lock timelines

The solution

EMAW Unified Platform

Agentic AI for real-time insights.

Derivative DataTransformational DataRaw Data
Agentic AI layer
Outlier & anomaly detectionInsights on demandComplete audit trailMultimodal analytics
Raw data outputs
Real-time data extracts via APIDatabase lock
Actionable outputs
Flags & alertsVisualizations & dashboardsHuman queriesAgentic AI queries
Study enhancements
Faster configurationQuicker site activationFaster database lockReal-time surveillanceReal-time anomaly detectionPhenotyping & signal detection
2–4 weeks Configuration2–4 weeks Database Lock
View full graphic ↗
Faster Configuration and Quicker Site Activation
Faster Database Lock
Real-Time Surveillance, Anomolies and Outliers
Signal Detection

Clinical Expertise is a Key Differentiation


Our clinical team works with you on study design, which informs platform configuration and generates targeted insights which drive real time decisions impacting subject selection, ratings, and site performance

 

Study Design

Data Interpretation and Analytics

Commercial case

Faster and better clinical decisions and mitigation of study execution risk

The value has its foundation in standardized data collection and storage. This enables real time insights and data access via API or DTS. The canonical data platform generates automated insights via flags and alerts, and derived insights from statistical programs, LLMs and agentic AI tools. The generation of alerts, anomalies and outliers requiring further review protects against clinical and operational risk in real time through faster, more confident decisions.

Screen better

We design screening programs using traditional primary endpoints, ecological momentary assessments, actigraphy, and digital biomarkers which together can trigger reviews of diagnostic interviews to ensure the right subjects are included in a trial.

Detect outliers and other signals earlier

Our canonical database generates access to raw, derivative and transformational data, and uses these data to provide real time insights to study teams which can truncate trial times and preclude rater and site performance issues which can lead to study execution risk. This is all done within our platform and does not require data extracts.

Core capabilities

Real-time insights for better in-study decisions

EMA Wellness integrates eCOA, EMAs, audio/video, sensor data, actigraphy, digital biomarkers, and passively collected Health App data into one clinical trial infrastructure. Standardized, analysis-ready data gives sponsors faster visibility into patient quality, endpoint reliability, operational risk, and emerging treatment signals.

Data foundation

Single cloud-based tech stack and code base to collect multimodal data agnostic to device, API or operating system, including eCOA, EMA, diary, passive health application (phone) and sensor data.

  • Utilize LLMs, stats programs and agentic AI models to generate evidence based signals for next generation qualitative enhancements around subject selection, rater surveillance and site quality control

Clinical value

We work with sponsors to design their protocols and clearly understand study objectives. We configure our platform to meet these objectives, including which data to collect, when, and how to identify signals which require further review and adjudication. Actionable data supports

  • Evidence based subject selection
  • Exponentially faster platform configuration and study/site activation
  • Faster database lock
  • Advanced AI driven rater and site surveillance
  • Real time access to raw, derivative and transformational data
  • Higher-powered trials run more quickly and efficiently
  • Focus on measurement of treatment effect and prediction
CleanerStandardized collection across modalities.
FasterImmediate access to scores and quality signals.
SmarterAI-enabled measures and signal detection.
ConnectedAPI-ready data access for sponsors.

 

Explore platform →